Talk:Roivant Sciences
Appearance
This is the talk page for discussing improvements to the Roivant Sciences article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Archives: 1Auto-archiving period: 5 months |
Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent. |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to multiple WikiProjects. | ||||||||||||||||||
|
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
Readability and Promotional language
[edit]It's hard to even tell what this company does with this language, full of jargon and overly promotional language. Does anyone have any info on what pharmaceuticals they sell? This currently reads like an investor report. Marleeashton (talk) 09:16, 26 August 2023 (UTC)
Revenue figure is wrong
[edit]Revue figure and op. income are not aligned ($M) vs ($B):
Revenue US$125 million (2024) Operating income US$4.24 billion (2024) 147.161.183.9 (talk) 12:36, 13 November 2024 (UTC)
- Thanks. Drove me nuts also 172.97.36.156 (talk) 01:36, 17 November 2024 (UTC)